Latest Stories
Uncategorized
AstraZeneca Partners With Tremont AI to Screen Drug Candidates for Toxicity Before Human Trials
AstraZeneca is working with startup Tremont AI to build AI models that flag potentially toxic drug candidates earlier in development, aiming to cut the cost and time lost to late-stage trial failures.
Uncategorized
Tempus AI’s $1.5 Billion Bid for Personalis Heads to a Shareholder Vote
Personalis shareholders of record as of October 15 will soon vote on Tempus AI's all-stock acquisition, a deal that would fold Personalis' cancer genomics testing into Tempus' AI-driven oncology data platform.
Uncategorized
AI Primary Care Study Finds Zero Safety Stops Across 114 Patients
A Lancet-published study of an AI system handling direct patient interactions in primary care reported no safety-related stops across 114 patients, a notable milestone for AI deployed in frontline clinical settings.
Uncategorized
Nursing’s Largest Group Launches $5 Million Push to Train Nurses on AI and Digital Health
The American Nurses Association has named a vice president of AI and Digital Health Programs to lead a three-year initiative backed by Johnson & Johnson Foundation and Google.org funding.
In-Depth
Uncategorized
Eli Lilly Signs a Second Major AI Deal — This Time for Drug Delivery, Not Discovery
Eli Lilly signed a roughly $1.1 billion AI drug delivery deal, separate from its earlier Insilico discovery partnership, extending AI across its pipeline.
Uncategorized
Abridge’s AI Scribe Business Pulls In Eli Lilly as a Strategic Backer After a $316 Million Funding Extension
Abridge closed a $316 million funding extension and added Eli Lilly as a strategic investor, pushing its AI scribe business deeper into billing automation.
Uncategorized
Neko Health Raises $700 Million and Opens Its First US Scanning Clinic as the AI Body-Scan Race Heats Up
Daniel Ek's Neko Health raised $700 million and opened its first US clinic in SoHo, betting that consumers will pay out of pocket for AI-driven preventive body scans.
Uncategorized
GSK Widens Its Chai Discovery Partnership — But Only After Its Own Scientists Double-Checked the AI’s Work
GSK expanded its Chai Discovery AI drug-design partnership only after its own scientists validated the results, reflecting pharma's cautious AI embrace.
Uncategorized
Cleveland Clinic’s AI Trial-Matching Tool Wins a Gartner Award After Enrolling Patients 40% Faster
Cleveland Clinic and Dyania Health won a Gartner innovation award for AI that reportedly sped up clinical trial patient enrollment by about 40%.
